FNY Investment Advisers’s Guardant Health GH Stock Holding History

FNY Investment Advisers’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,200	Closed	-$62K	–	1333
2025 Q2	$62K	Buy	+1,200	New	+$53.6K	0.03%	360
2023 Q2	–	Sell	-1,830	Closed	-$42K	–	593
2023 Q1	$42K	Buy	1,830 +36	+2%	+$1.03K	0.05%	197
2022 Q4	$48K	Buy	+1,794	New	+$82.1K	0.07%	186
2022 Q2	–	Sell	-152	Closed	-$10K	–	776
2022 Q1	$10K	Buy	+152	New	+$10.4K	0.01%	450
2020 Q1	–	Sell	-2,683	Closed	-$209K	–	590
2019 Q4	$209K	Buy	+2,683	New	+$193K	0.06%	236
2019 Q3	–	Sell	-950	Closed	-$83.7K	–	977
2019 Q2	$82K	Buy	950 +943	+13,471%	+$72K	0.02%	270
2019 Q1	$0	Buy	+7	New	+$388	﹤0.01%	777

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

FNY Investment Advisers's GH Position: Q3 2025 in Review

FNY Investment Advisers sold out of Guardant Health (GH) in Q3 2025, closing a stake of 1,200 shares — an estimated $62K sold.

FNY Investment Advisers first reported a position in GH in Q1 2019 and held it in 7 quarters. The position peaked at $209K in Q4 2019. 395 funds tracked by Wall St. Rank hold GH as of Q3 2025.

FNY Investment Advisers reported no remaining Guardant Health position as of Q3 2025 after selling out during the quarter.
FNY Investment Advisers sold 1,200 Guardant Health shares in Q3 2025, an estimated $62K.
FNY Investment Advisers first reported a position in Guardant Health in Q1 2019 and held it in 7 quarters.
FNY Investment Advisers's Guardant Health position peaked at $209K in Q4 2019.
395 funds tracked by Wall St. Rank held Guardant Health as of Q3 2025.

Based on FNY Investment Advisers's 13F filing for Q3 2025, filed 15 Dec 2025.